BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Groome MJ, Moon SS, Velasquez D, Jones S, Koen A, van Niekerk N, Jiang B, Parashar UD, Madhi SA. Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa. Bull World Health Organ 2014;92:238-45. [PMID: 24700991 DOI: 10.2471/BLT.13.128066] [Cited by in Crossref: 63] [Cited by in F6Publishing: 35] [Article Influence: 7.9] [Reference Citation Analysis]
Number Citing Articles
1 Jansen MA, van den Heuvel D, van Zelm MC, Jaddoe VW, Hofman A, de Jongste JC, Hooijkaas H, Moll HA. Decreased memory B cells and increased CD8 memory T cells in blood of breastfed children: the generation R study. PLoS One 2015;10:e0126019. [PMID: 25993335 DOI: 10.1371/journal.pone.0126019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
2 Ali A, Kazi AM, Cortese MM, Fleming JA, Moon S, Parashar UD, Jiang B, McNeal MM, Steele D, Bhutta Z, Zaidi AK. Impact of withholding breastfeeding at the time of vaccination on the immunogenicity of oral rotavirus vaccine--a randomized trial. PLoS One 2015;10:e0127622. [PMID: 26035743 DOI: 10.1371/journal.pone.0127622] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 6.6] [Reference Citation Analysis]
3 Savulescu DM, Groome M, Malfeld SCK, Madhi S, Koen A, Jones S, Duxbury V, Scheuermaier K, De Assis Rosa D, Suchard M. HLA antibody repertoire in infants suggests selectivity in transplacental crossing. Am J Reprod Immunol 2020;84:e13264. [PMID: 32395838 DOI: 10.1111/aji.13264] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Rudd C, Mwenda J, Chilengi R. Rotavirus landscape in Africa-Towards prevention and control: A report of the 8th African rotavirus symposium, Livingstone, Zambia. Vaccine 2015;33:3263-7. [PMID: 25957665 DOI: 10.1016/j.vaccine.2015.04.002] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
5 Kumar P, Pullagurla SR, Patel A, Shukla RS, Bird C, Kumru OS, Hamidi A, Hoeksema F, Yallop C, Bines JE, Joshi SB, Volkin DB. Effect of Formulation Variables on the Stability of a Live, Rotavirus (RV3-BB) Vaccine Candidate using in vitro Gastric Digestion Models to Mimic Oral Delivery. J Pharm Sci 2021;110:760-70. [PMID: 33035539 DOI: 10.1016/j.xphs.2020.09.047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Kazimbaya KM, Chisenga CC, Simuyandi M, Phiri CM, Laban NM, Bosomprah S, Permar SR, Munsaka S, Chilengi R. In-vitro inhibitory effect of maternal breastmilk components on rotavirus vaccine replication and association with infant seroconversion to live oral rotavirus vaccine. PLoS One 2020;15:e0240714. [PMID: 33170860 DOI: 10.1371/journal.pone.0240714] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Becker-Dreps S, Choi WS, Stamper L, Vilchez S, Velasquez DE, Moon SS, Hudgens MG, Jiang B, Permar SR. Innate Immune Factors in Mothers' Breast Milk and Their Lack of Association With Rotavirus Vaccine Immunogenicity in Nicaraguan Infants. J Pediatric Infect Dis Soc 2017;6:87-90. [PMID: 26582774 DOI: 10.1093/jpids/piv076] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
8 Asare EO, Al-Mamun MA, Armah GE, Lopman BA, Parashar UD, Binka F, Pitzer VE. Modeling of rotavirus transmission dynamics and impact of vaccination in Ghana. Vaccine 2020;38:4820-8. [PMID: 32513513 DOI: 10.1016/j.vaccine.2020.05.057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Hull JJ, Cunliffe N, Jere KC, Moon SS, Wang Y, Parashar U, Jiang B. Rotavirus antigen, cytokine, and neutralising antibody profiles in sera of children with and without HIV infection in Blantyre, Malawi. Malawi Med J 2017;29:24-8. [PMID: 28567192 DOI: 10.4314/mmj.v29i1.5] [Reference Citation Analysis]
10 Tate JE, Arora R, Bhan MK, Yewale V, Parashar UD, Kang G. Rotavirus disease and vaccines in India: a tremendous public health opportunity. Vaccine 2014;32 Suppl 1:vii-xii. [PMID: 25091690 DOI: 10.1016/j.vaccine.2014.05.047] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Shah MP, Tate JE, Mwenda JM, Steele AD, Parashar UD. Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa. Expert Rev Vaccines 2017;16:987-95. [PMID: 28832219 DOI: 10.1080/14760584.2017.1371595] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 7.2] [Reference Citation Analysis]
12 Mwila K, Chilengi R, Simuyandi M, Permar SR, Becker-Dreps S. Contribution of Maternal Immunity to Decreased Rotavirus Vaccine Performance in Low- and Middle-Income Countries. Clin Vaccine Immunol 2017;24:e00405-16. [PMID: 27847365 DOI: 10.1128/CVI.00405-16] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
13 Otero CE, Langel SN, Blasi M, Permar SR. Maternal antibody interference contributes to reduced rotavirus vaccine efficacy in developing countries. PLoS Pathog 2020;16:e1009010. [PMID: 33211756 DOI: 10.1371/journal.ppat.1009010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
14 Praharaj I, John SM, Bandyopadhyay R, Kang G. Probiotics, antibiotics and the immune responses to vaccines. Philos Trans R Soc Lond B Biol Sci 2015;370:20140144. [PMID: 25964456 DOI: 10.1098/rstb.2014.0144] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
15 Chilengi R, Simuyandi M, Beach L, Mwila K, Becker-Dreps S, Emperador DM, Velasquez DE, Bosomprah S, Jiang B. Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants. PLoS One 2016;11:e0150100. [PMID: 26974432 DOI: 10.1371/journal.pone.0150100] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
16 Wang Y, Vlasova A, Velasquez DE, Saif LJ, Kandasamy S, Kochba E, Levin Y, Jiang B. Skin Vaccination against Rotavirus Using Microneedles: Proof of Concept in Gnotobiotic Piglets. PLoS One 2016;11:e0166038. [PMID: 27824918 DOI: 10.1371/journal.pone.0166038] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
17 Desselberger U. Differences of Rotavirus Vaccine Effectiveness by Country: Likely Causes and Contributing Factors. Pathogens 2017;6:E65. [PMID: 29231855 DOI: 10.3390/pathogens6040065] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 12.2] [Reference Citation Analysis]
18 Steele AD, Victor JC, Carey ME, Tate JE, Atherly DE, Pecenka C, Diaz Z, Parashar UD, Kirkwood CD. Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries? Hum Vaccin Immunother 2019;15:1215-27. [PMID: 30735087 DOI: 10.1080/21645515.2018.1553593] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
19 Dai X, Bai R, Jian M, Ji Z, Ding Z, Wang F, Bi Y, Manzamaesso A, Chen T, Luo L, Liu A, Bao F. Immunogenicity of different dosing schedules of the human live attenuate rotavirus vaccine (RV1) in infants and children: a meta-analysis. Hum Vaccin Immunother 2019;15:1228-36. [PMID: 30346870 DOI: 10.1080/21645515.2018.1537742] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 Higashimoto Y, Ihira M, Miyazaki Y, Kuboshiki A, Yoshinaga S, Hiramatsu H, Suzuki R, Miyata M, Miura H, Komoto S, Yukitake J, Taniguchi K, Kawamura Y, Yoshikawa T. Monitoring Shedding of Five Genotypes of RotaTeq Vaccine Viruses by Genotype-Specific Real-Time Reverse Transcription-PCR Assays. J Clin Microbiol 2018;56:e00035-18. [PMID: 29563200 DOI: 10.1128/JCM.00035-18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
21 Aliabadi N, Tate JE, Parashar UD. Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines. Clin Microbiol Infect 2016;22 Suppl 5:S128-35. [PMID: 27129416 DOI: 10.1016/j.cmi.2016.03.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
22 Chen MY, Kirkwood CD, Bines J, Cowley D, Pavlic D, Lee KJ, Orsini F, Watts E, Barnes G, Danchin M. Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand. Hum Vaccin Immunother 2017;13:1126-35. [PMID: 28059609 DOI: 10.1080/21645515.2016.1274474] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
23 Ahmad S, Ullah A, Arfan M, Shah K. On analysis of the fractional mathematical model of rotavirus epidemic with the effects of breastfeeding and vaccination under Atangana-Baleanu (AB) derivative. Chaos, Solitons & Fractals 2020;140:110233. [DOI: 10.1016/j.chaos.2020.110233] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 10.0] [Reference Citation Analysis]
24 Emperador DM, Velasquez DE, Estivariz CF, Lopman B, Jiang B, Parashar U, Anand A, Zaman K. Interference of Monovalent, Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh. Clin Infect Dis 2016;62:150-6. [PMID: 26349548 DOI: 10.1093/cid/civ807] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.9] [Reference Citation Analysis]
25 Bennett A, Pollock L, Jere KC, Pitzer VE, Lopman B, Parashar U, Everett D, Heyderman RS, Bar-Zeev N, Cunliffe NA, Iturriza-Gomara M. Infrequent Transmission of Monovalent Human Rotavirus Vaccine Virus to Household Contacts of Vaccinated Infants in Malawi. J Infect Dis 2019;219:1730-4. [PMID: 30689911 DOI: 10.1093/infdis/jiz002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
26 Folorunso OS, Sebolai OM. Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines. Vaccines (Basel) 2020;8:E341. [PMID: 32604982 DOI: 10.3390/vaccines8030341] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
27 Burnett E, Yen C, Tate JE, Parashar UD. Rotavirus vaccines: current global impact and future perspectives. Future Virol 2016;11:699-708. [PMID: 27840654 DOI: 10.2217/fvl-2016-0082] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
28 Burnett E, Parashar U, Tate J. Rotavirus Vaccines: Effectiveness, Safety, and Future Directions. Paediatr Drugs 2018;20:223-33. [PMID: 29388076 DOI: 10.1007/s40272-018-0283-3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 11.8] [Reference Citation Analysis]
29 Lee B. Update on rotavirus vaccine underperformance in low- to middle-income countries and next-generation vaccines. Hum Vaccin Immunother 2021;17:1787-802. [PMID: 33327868 DOI: 10.1080/21645515.2020.1844525] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
30 Sinha A, Kanungo S, Kim DR, Manna B, Song M, Park JY, Haldar B, Sharma P, Mallick AH, Kim SA, Babji S, Sur D, Kang G, Ali M, Petri WA Jr, Wierzba TF, Czerkinsky C, Nandy RK, Dey A. Antibody secreting B cells and plasma antibody response to rotavirus vaccination in infants from Kolkata India. Heliyon 2018;4:e00519. [PMID: 29560435 DOI: 10.1016/j.heliyon.2018.e00519] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
31 Parker EP, Ramani S, Lopman BA, Church JA, Iturriza-Gómara M, Prendergast AJ, Grassly NC. Causes of impaired oral vaccine efficacy in developing countries. Future Microbiol 2018;13:97-118. [PMID: 29218997 DOI: 10.2217/fmb-2017-0128] [Cited by in Crossref: 78] [Cited by in F6Publishing: 70] [Article Influence: 15.6] [Reference Citation Analysis]
32 Babji S, Manickavasagam P, Chen YH, Jeyavelu N, Jose NV, Praharaj I, Syed C, Kaliappan SP, John J, Giri S, Venugopal S, Kampmann B, Parker EPK, Iturriza-Gómara M, Kang G, Grassly NC, Uhlig HH. Immune predictors of oral poliovirus vaccine immunogenicity among infants in South India. NPJ Vaccines 2020;5:27. [PMID: 32218999 DOI: 10.1038/s41541-020-0178-5] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Vlasova AN, Takanashi S, Miyazaki A, Rajashekara G, Saif LJ. How the gut microbiome regulates host immune responses to viral vaccines. Curr Opin Virol 2019;37:16-25. [PMID: 31163292 DOI: 10.1016/j.coviro.2019.05.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
34 Mwila-Kazimbaya K, Garcia MP, Bosomprah S, Laban NM, Chisenga CC, Permar SR, Simuyandi M, Munsaka S, Chilengi R. Effect of innate antiviral glycoproteins in breast milk on seroconversion to rotavirus vaccine (Rotarix) in children in Lusaka, Zambia. PLoS One 2017;12:e0189351. [PMID: 29284036 DOI: 10.1371/journal.pone.0189351] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
35 Becker-Dreps S, Vilchez S, Velasquez D, Moon SS, Hudgens MG, Zambrana LE, Jiang B. Rotavirus-specific IgG antibodies from mothers' serum may inhibit infant immune responses to the pentavalent rotavirus vaccine. Pediatr Infect Dis J 2015;34:115-6. [PMID: 25741808 DOI: 10.1097/INF.0000000000000481] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 4.1] [Reference Citation Analysis]
36 O'Ryan M. Rotavirus Vaccines: a story of success with challenges ahead. F1000Res 2017;6:1517. [PMID: 28928954 DOI: 10.12688/f1000research.11912.1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
37 Saso A, Kampmann B. Maternal Immunization: Nature Meets Nurture. Front Microbiol 2020;11:1499. [PMID: 32849319 DOI: 10.3389/fmicb.2020.01499] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
38 Kumar A, Helmy YA, Fritts Z, Vlasova A, Saif LJ, Rajashekara G. Anti-rotavirus Properties and Mechanisms of Selected Gram-Positive and Gram-Negative Probiotics on Polarized Human Colonic (HT-29) Cells. Probiotics Antimicrob Proteins 2022. [PMID: 35034323 DOI: 10.1007/s12602-021-09884-3] [Reference Citation Analysis]
39 Tissera MS, Cowley D, Bogdanovic-Sakran N, Hutton ML, Lyras D, Kirkwood CD, Buttery JP. Options for improving effectiveness of rotavirus vaccines in developing countries. Hum Vaccin Immunother 2017;13:921-7. [PMID: 27835052 DOI: 10.1080/21645515.2016.1252493] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]